Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JRD
|
|||
| Former ID |
DIB013522
|
|||
| Drug Name |
VT-310
|
|||
| Synonyms |
VT-310 (inflammation); IL-10 homologue (inflammation), Viron; VT-310 (inflammation), Viron
Click to Show/Hide
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
| Company |
Viron Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interleukin 10 receptor (IL10RB) | Target Info | Modulator | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| Toxoplasmosis | ||||
| Tuberculosis | ||||
| Epstein-Barr virus infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1900). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.